DAM: Diaphragm Atrophy and Dysfunction in Mechanical Ventilation

Sponsor
RWTH Aachen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05211661
Collaborator
(none)
15
1
18.7
0.8

Study Details

Study Description

Brief Summary

The gold standard of twitch transdiaphragmatic pressure recordings would ultimately clear the fog around the rate of development of Ventilator induced Diaphragm Dysfunction (VIDD) in mechanically ventilated patients over time.

Through measurements made even after mechanical ventilation (MV) it could be clarified to what extent patients recover from VIDD.

Paired with cortical stimulation and electromyographic recordings of diaphragm muscle potentials, it could be explored to what extent decreased diaphragm excitability due to long term MV contributes to VIDD on the level of motor cortex.

Against that background the present project aims at determining the rate of decline in diaphragm function, strength and control in patients undergoing MV (including measurements after extubation).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Respiratory Muscle Testing

Detailed Description

Evidence both from animal and human studies support the development of ventilator induced diaphragm dysfunction (VIDD) from as early as 24 hours of mechanical ventilation (MV) in the intensive care unit (ICU).

However, while the concept of VIDD seems to be proven now, several questions remain unanswered regarding its actual rate of development and (potentially) recovery after MV.

The gold standard of twitch transdiaphragmatic pressure recordings would ultimately clear the fog around the rate of development of VIDD over time.

Through measurements made even after MV it could be clarified to what extent patients recover from VIDD.

Paired with cortical stimulation and electromyographic recordings of diaphragm muscle potentials, it could be explored to what extent decreased diaphragm excitability due to long term MV contributes to VIDD on the level of motor cortex.

Against that background the present project aims at determining the rate of decline in diaphragm function, strength and control in patients undergoing MV (including measurements after extubation).

Study Design

Study Type:
Observational
Anticipated Enrollment :
15 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Development of Diaphragm Atrophy, Dysfunction and Inhibited Cortical Control in Mechanical Ventilation
Anticipated Study Start Date :
May 10, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Invasively ventilated patients (n=15)

First measurement (comprehensive protocol) within 48 hours from initiation of MV. Serial measurements every third day including 2 measurements after extubation.

Diagnostic Test: Respiratory Muscle Testing
Comprehensive assessment of respiratory muscle function. Comprehensive assessment of respiratory muscle function to the point of its invasive assessment with recordings of twitch transdiaphragmatic pressure in response to magnetic phrenic nerve stimulation and stimulation of the lower thoracic nerve roots.

Outcome Measures

Primary Outcome Measures

  1. Twitch transdiaphragmatic pressure in response to supramaximal magnetic stimulation of the phrenic nerve roots. [2 years]

  2. Cortical control of diaphragm function [2 years]

    Amplitude of the diaphragm motor evoked potentials (measured by surface electrodes attached to the diaphragm) following cortical magnetic stimulation of the phrenic nerve roots.

Secondary Outcome Measures

  1. Diaphragm ultrasound [2 years]

    Diaphragm thickening fraction on ultrasound

  2. Systemic inflammation [2 years]

    Concentration of circulating Interleukin, high-sensitivity C-reactive protein (analyzed quantitatively based on a Levels venous blood sample).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Initiation of invasive mechanical ventilation in the Intensive Care Unit within 48 hours.

  • Expected duration of invasive mechanical ventilation of at least 5 days.

Exclusion Criteria:
  • Body-mass-index (BMI) >40

  • Expected absence of active participation of the patient in study-related measurements after extubation

  • Alcohol or drug abuse

  • Non MRI compatible implant in the body

  • Slipped disc

  • Epilepsy

  • Patients in an interdependence or with an employment contract with the principal investigator, Co-PI or his deputy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 RWTH Aachen University Aachen Germany 52074

Sponsors and Collaborators

  • RWTH Aachen University

Investigators

  • Study Chair: Michael Dreher, Professor, RWTH Aachen University Hospital
  • Principal Investigator: Jens Spiesshoefer, MD, RWTH Aachen University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Univ.-Prof. Dr. med. Michael Dreher, Professor Michael Dreher, RWTH Aachen University
ClinicalTrials.gov Identifier:
NCT05211661
Other Study ID Numbers:
  • CTCA 21-279
First Posted:
Jan 27, 2022
Last Update Posted:
May 3, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 3, 2022